| pubmed-article:1627171 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1627171 | lifeskim:mentions | umls-concept:C0206318 | lld:lifeskim |
| pubmed-article:1627171 | lifeskim:mentions | umls-concept:C0042479 | lld:lifeskim |
| pubmed-article:1627171 | lifeskim:mentions | umls-concept:C0031667 | lld:lifeskim |
| pubmed-article:1627171 | lifeskim:mentions | umls-concept:C0312586 | lld:lifeskim |
| pubmed-article:1627171 | lifeskim:mentions | umls-concept:C1521827 | lld:lifeskim |
| pubmed-article:1627171 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:1627171 | lifeskim:mentions | umls-concept:C1998793 | lld:lifeskim |
| pubmed-article:1627171 | lifeskim:mentions | umls-concept:C1407029 | lld:lifeskim |
| pubmed-article:1627171 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:1627171 | pubmed:dateCreated | 1992-8-13 | lld:pubmed |
| pubmed-article:1627171 | pubmed:abstractText | Vipera russelli venom induces predominantly neurotoxic, myotoxic necrotic and hemorrhagic symptoms in experimental animals and has several hydrolytic enzyme activities. In this study, V. russelli venom is characterized both as a PLA2 and as a toxin. Anti PL-V Ig (antibodies to a toxic phospholipase A2 VRV PL-V of V. russelli venom) nullifies the toxicity of whole V. russelli venom to a great extent. The neurotoxic symptoms vanish completely in the presence of anti PL-V Ig. The cross reacting components of whole V. russelli venom were removed by precipitating them from whole venom by the addition of anti PL-V Ig. The non-cross reacting components present in the supernatant were checked for toxicity. There was a significant reduction in toxicity. The LD50 value of the supernatant had increased from 4.1 mg/kg body weight to 11.7 mg/kg body weight and it showed about 34% of the total venom phospholipase A2 activity. It had edema forming, hemorrhagic and hemolytic activity but failed to induce neurotoxic, anticoagulant and myotoxic effects. | lld:pubmed |
| pubmed-article:1627171 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1627171 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1627171 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1627171 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1627171 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1627171 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1627171 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1627171 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1627171 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1627171 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:1627171 | pubmed:issn | 0158-5231 | lld:pubmed |
| pubmed-article:1627171 | pubmed:author | pubmed-author:GowdaT VTV | lld:pubmed |
| pubmed-article:1627171 | pubmed:author | pubmed-author:KasturiSS | lld:pubmed |
| pubmed-article:1627171 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1627171 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:1627171 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1627171 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1627171 | pubmed:pagination | 155-64 | lld:pubmed |
| pubmed-article:1627171 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:1627171 | pubmed:meshHeading | pubmed-meshheading:1627171-... | lld:pubmed |
| pubmed-article:1627171 | pubmed:meshHeading | pubmed-meshheading:1627171-... | lld:pubmed |
| pubmed-article:1627171 | pubmed:meshHeading | pubmed-meshheading:1627171-... | lld:pubmed |
| pubmed-article:1627171 | pubmed:meshHeading | pubmed-meshheading:1627171-... | lld:pubmed |
| pubmed-article:1627171 | pubmed:meshHeading | pubmed-meshheading:1627171-... | lld:pubmed |
| pubmed-article:1627171 | pubmed:meshHeading | pubmed-meshheading:1627171-... | lld:pubmed |
| pubmed-article:1627171 | pubmed:meshHeading | pubmed-meshheading:1627171-... | lld:pubmed |
| pubmed-article:1627171 | pubmed:meshHeading | pubmed-meshheading:1627171-... | lld:pubmed |
| pubmed-article:1627171 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1627171 | pubmed:articleTitle | Analysis of Vipera russelli venom using polyclonal antibodies prepared against its purified toxic phospholipase A2 VRV PL-V. | lld:pubmed |
| pubmed-article:1627171 | pubmed:affiliation | Department of studies in Biochemistry, University of Mysore, India. | lld:pubmed |
| pubmed-article:1627171 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1627171 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
